Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2005, p. 144-149, Vol. 43, No. 1
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.1.144-149.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Neisseria Unit and the French National Reference Center for Meningococci, Institut Pasteur, Paris, France,1 Irish Meningococcal and Meningitis Reference Laboratory, The Children's University Hospital, Dublin, Ireland,2 WHO Collaborating Center for Reference and Research on Meningococci, Division of Infectious Disease Control, Norwegian Institute of Public Health,3 Institute of Oral Biology, University of Oslo, Oslo, Norway,4 Scottish Meningococcus and Pneumococcus Reference Laboratory, Stobhill Hospital,5 Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow,6 Meningococcal Reference Unit, Health Protection Agency, Manchester Royal Infirmary, Manchester, United Kingdom,7 Institute for Hygiene and Microbiology, National Reference Center for Meningococci, University of Würzburg, Germany,8 National Reference Centre for Meningococci, Austrian Agency for Health and Food Safety, Graz, Austria,9 National Reference Laboratory for Meningococcal Infections, National Institute of Public Health, Prague, Czech Republic,10 National Meningococcal Reference Laboratory, NIPH, Athens, Greece,11 National Reference Laboratory for Pathogenic Neisseria, Department of Clinical Microbiology, University Hospital, Örebro, Sweden,12 Centre Muraz, Bobo Dioulasso, Burkina Faso,13
Received 1 June 2004/ Returned for modification 19 July 2004/ Accepted 31 August 2004
Twenty clinical samples (18 cerebrospinal fluid samples and 2 articular fluid samples) were sent to 11 meningococcus reference centers located in 11 different countries. Ten of these laboratories are participating in the EU-MenNet program (a European Union-funded program) and are members of the European Monitoring Group on Meningococci. The remaining laboratory was located in Burkina Faso. Neisseria meningitidis was sought by detecting several meningococcus-specific genes (crgA, ctrA, 16S rRNA, and porA). The PCR-based nonculture method for the detection of N. meningitidis gave similar results between participants with a mean sensitivity and specificity of 89.7 and 92.7%, respectively. Most of the laboratories also performed genogrouping assays (siaD and mynB/sacC). The performance of genogrouping was more variable between laboratories, with a mean sensitivity of 72.7%. Genogroup B gave the best correlation between participants, as all laboratories routinely perform this PCR. The results for genogroups A and W135 were less similar between the eight participating laboratories that performed these PCRs.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|